HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment | HDFC Pharma and Healthcare Fund NAV Today [19.96], Performance & History

Equity Sectoral Thematic Regular

Regular

Direct

2 Year Absolute Returns

52.16% ↑

NAV (₹) on 19 Jun 2026

19.96

1 Day NAV Change

0.99%

Risk Level

Very High Risk

Rating

HDFC Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by HDFC Asset Management Company Ltd.. Launched on 14 Sep 2023, investors can start with a minimum SIP of ₹100 ... Read more

NAV History

Fund Details

Min. SIP Amount

₹100

Inception Date

14 Sep 2023

Min. Lumpsum Amount

₹ 100

Fund Age

2 Yrs

AUM

₹ 2,362.44 Cr.

Benchmark

BSE Healthcare

Expense Ratio

1.97%

Scheme Type

Open Ended

Exit Load

Asset Allocation

AUM

₹ 2,362.44 Cr

Equity

491.93%

Money Market & Cash

8.47%

Other Assets & Liabilities

0.79%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	71.18%
Hospitals & Medical Services	26.87%
Treps/Reverse Repo	1.49%
Medical Equipment & Accessories	0.63%

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
Sun Pharmaceutical Industries Ltd.	9.20%	₹ 217.44	Pharmaceuticals
Divis Laboratories Ltd.	8.02%	₹ 189.40	Pharmaceuticals
Lupin Ltd.	5.45%	₹ 128.87	Pharmaceuticals
Max Healthcare Institute Limited	5.26%	₹ 124.37	Hospitals & Medical Services
Aster DM Healthcare Limited	5.18%	₹ 122.44	Hospitals & Medical Services
Cipla Ltd.	4.92%	₹ 116.29	Pharmaceuticals
Acutaas Chemicals Limited	4.50%	₹ 106.19	Pharmaceuticals
Alkem Laboratories Ltd.	4.36%	₹ 103.08	Pharmaceuticals
Anthem Biosciences Limited	4.15%	₹ 98.16	Pharmaceuticals
Ipca Laboratories Ltd.	3.50%	₹ 82.58	Pharmaceuticals
Fortis Healthcare Limited	3.41%	₹ 80.49	Hospitals & Medical Services
Glenmark Pharmaceuticals Ltd.	3.28%	₹ 77.55	Pharmaceuticals
Laurus Labs Ltd.	3.17%	₹ 74.82	Pharmaceuticals
Krishna Institute Of Medical Sciences Limited	3.16%	₹ 74.72	Hospitals & Medical Services
Global Health Limited	3.08%	₹ 72.76	Hospitals & Medical Services
Neuland Laboratories Limited	2.98%	₹ 70.43	Pharmaceuticals
Vijaya Diagnostic Centre Limited	2.70%	₹ 63.87	Hospitals & Medical Services
Metropolis Healthcare Ltd.	2.54%	₹ 60.06	Hospitals & Medical Services
Zydus Lifesciences Limited	2.50%	₹ 59.15	Pharmaceuticals
Wockhardt Ltd.	2.44%	₹ 57.55	Pharmaceuticals
Shilpa Medicare Ltd	2.28%	₹ 53.92	Pharmaceuticals
Sai Life Sciences Limited	1.78%	₹ 41.99	Pharmaceuticals
Eris Lifesciences Ltd	1.61%	₹ 37.96	Pharmaceuticals
Thyrocare Technologies Ltd.	1.54%	₹ 36.41	Hospitals & Medical Services
TREPS - Tri-party Repo	1.49%	₹ 35.12	Others
Rubicon Research Limited	1.35%	₹ 31.90	Pharmaceuticals
Jubilant Pharmova Limited	1.34%	₹ 31.60	Pharmaceuticals
Biocon Ltd.	1.33%	₹ 31.43	Pharmaceuticals
Gland Pharma Ltd.	1.19%	₹ 28.17	Pharmaceuticals
BAJAJ HEALTHCARE LIMITED	0.73%	₹ 17.19	Pharmaceuticals
Novartis India Ltd.	0.64%	₹ 15.10	Pharmaceuticals
Laxmi Dental Limited	0.63%	₹ 14.99	Medical Equipment & Accessories
Cohance Lifesciences Limited	0.46%	₹ 10.79	Pharmaceuticals

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	13.08%	22.80%	23.35%	-
Category returns	1.21%	5.68%	6.27%	22.53%

Fund Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of ... Read more

AMC Details

Name

HDFC Asset Management Company Ltd.

Date of Incorporation

30 Jun 2000

CEO

Mr. Navneet Munot

CIO

Type

Pvt.Sector-Joint Venture (Indian)

Address

HDFC House, 2nd Floor, H T Parekh Marg, 165-166, Backbay Reclamation, Churchgate, Mumbai, Maharashtra, India - 400020

Website

http://www.hdfcfund.com

[email protected]

Top Funds from Equity - Sectoral/Thematic

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund Sector Regular	₹29.45	17.51%	191.18%	0.00%	₹9,724	1.75%	Very High

Top Funds from HDFC Asset Management Company Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
HDFC Silver ETF ETF Regular	₹220.04	111.66%	208.25%	0.00%	₹8,257	0.50%	Very High
HDFC Silver ETF Fund of Fund - Direct Plan Fund of Funds Direct	₹38.23	110.72%	206.28%	0.00%	₹4,894	0.21%	Very High
HDFC Silver ETF Fund of Fund Fund of Funds Regular	₹37.71	109.90%	203.06%	0.00%	₹4,894	0.55%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund Sector Regular	₹29.45	17.51%	191.18%	0.00%	₹9,724	1.75%	Very High
HDFC Defence Fund Sector Regular	₹29.45	17.51%	191.18%	0.00%	₹9,724	1.75%	Very High
HDFC Defence Fund Sector Regular	₹29.45	17.51%	191.18%	0.00%	₹9,724	1.75%	Very High
HDFC Gold ETF Fund of Fund - Direct Plan Fund of Funds Direct	₹45.19	44.75%	137.52%	191.98%	₹12,121	0.20%	High

FAQs

What is the current NAV of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?

The current Net Asset Value (NAV) of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment is ₹19.96 as of 19 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What is the fund size (AUM) of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?

The Assets Under Management (AUM) of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment is ₹2,362.44 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the historical returns of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?

HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment has delivered returns of 22.80% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?

HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?

The minimum lumpsum investment required for HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment is ₹100. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article